OSM and cardiomyopathy: Oncostatin M is a controversial factor in cardiomyopathy and fibrosis; in myocardial infarction models, however, it causes partial cardiomyocyte dedifferentiation and initially protects damaged myocardium, but long-term induction promotes chronic heart failure (28) and inhibits excessive fibrosis in pressure-overload heart failure models (24).